We are live on ! Find out more
GSEP

Golden State Equity Partners Portfolio holdings

AUM $1.32B
1-Year Est. Return 23.87%
This Fund
S&P 500
This Quarter Est. Return
-0.42%
1 Year Est. Return
+23.87%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.32B
AUM Growth
+$702M
Cap. Flow
+$741M
Cap. Flow %
56.08%
Top 10 Hldgs %
22.01%
Holding
2,081
New
1,578
Increased
399
Reduced
80
Closed
5

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$37.5M
2
AAPL icon
Apple
AAPL
+$36.9M
3
MSFT icon
Microsoft
MSFT
+$14.6M
4
AMZN icon
Amazon
AMZN
+$12.6M
5
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$11.9M

Sector Composition

Rank Sector Weight
1 Technology 19.09%
2 Financials 6.84%
3 Healthcare 5.22%
4 Consumer Discretionary 4.91%
5 Industrials 4.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMF icon
1426
OneMain Financial
OMF
$6.97B
$5.35K ﹤0.01%
+100
New +$5.93K
FRO icon
1427
Frontline
FRO
$8.12B
$5.23K ﹤0.01%
+150
New +$4.58K
BROS icon
1428
Dutch Bros
BROS
$9.38B
$5.22K ﹤0.01%
+103
New +$5.63K
BSM icon
1429
Black Stone Minerals
BSM
$3.04B
$5.22K ﹤0.01%
+345
New +$5.12K
TM icon
1430
Toyota
TM
$210B
$5.15K ﹤0.01%
+25
New +$5.65K
URNJ icon
1431
Sprott Junior Uranium Miners ETF
URNJ
$299M
$5.13K ﹤0.01%
+175
New +$5.62K
IVZ icon
1432
Invesco
IVZ
$13.1B
$5.12K ﹤0.01%
+211
New +$5.52K
IDXX icon
1433
Idexx Laboratories
IDXX
$44.8B
$5.06K ﹤0.01%
+9
New +$5.77K
ANF icon
1434
Abercrombie & Fitch
ANF
$4.23B
$5.02K ﹤0.01%
+55
New +$5.35K
CRL icon
1435
Charles River Laboratories
CRL
$10.8B
$5K ﹤0.01%
+29
New +$5.38K
GMED icon
1436
Globus Medical
GMED
$10.5B
$5K ﹤0.01%
+58
New +$5.21K
FIGB icon
1437
Fidelity Investment Grade Bond ETF
FIGB
$507M
$4.95K ﹤0.01%
+115
New +$5K
JHX icon
1438
James Hardie Industries
JHX
$15B
$4.92K ﹤0.01%
+260
New +$5.85K
NE icon
1439
Noble Corp
NE
$6.62B
$4.91K ﹤0.01%
+100
New +$4.08K
ABX
1440
Abacus Global Management
ABX
$994M
$4.88K ﹤0.01%
+620
New +$5.38K
HP icon
1441
Helmerich & Payne
HP
$3.41B
$4.86K ﹤0.01%
+135
New +$4.6K
EFX icon
1442
Equifax
EFX
$21.1B
$4.86K ﹤0.01%
+27
New +$5.36K
HXL icon
1443
Hexcel
HXL
$7.83B
$4.86K ﹤0.01%
+60
New +$5.05K
TMQ
1444
Trilogy Metals
TMQ
$515M
$4.85K ﹤0.01%
+1,350
New +$6.16K
DLTR icon
1445
Dollar Tree
DLTR
$24.2B
$4.82K ﹤0.01%
+44
New +$5.38K
PNBK icon
1446
Patriot National Bancorp
PNBK
$140M
$4.77K ﹤0.01%
+3,700
New +$5.33K
PRM icon
1447
Perimeter Solutions
PRM
$5.61B
$4.76K ﹤0.01%
+195
New +$4.98K
HYFI icon
1448
AB High Yield ETF
HYFI
$328M
$4.68K ﹤0.01%
+126
New +$4.73K
VKTX icon
1449
Viking Therapeutics
VKTX
$4.31B
$4.65K ﹤0.01%
+143
New +$4.6K
NI icon
1450
NiSource
NI
$22B
$4.62K ﹤0.01%
+99
New +$4.46K

Similar funds

Golden State Equity Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Golden State Equity Partners held 2,081 positions worth $1.32B, up 113% from $620M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Golden State Equity Partners deployed $741M of net new capital in Q1 2026, opening 1,578 new positions and adding to 399 existing holdings. Its largest new stake was Gilead Sciences: 69,520 shares worth $9.69M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street Industrial Select Sector SPDR ETF, an estimated $781K trimmed.

  • Golden State Equity Partners's largest Q1 2026 buy was Gilead Sciences: 69,520 shares worth $9.69M.
  • Golden State Equity Partners added most to NVIDIA in Q1 2026, an estimated $37.5M increase.
  • Golden State Equity Partners's biggest Q1 2026 reduction was State Street Industrial Select Sector SPDR ETF, cutting an estimated $781K.
  • Golden State Equity Partners fully exited Ferrari in Q1 2026, selling an estimated $276K.
  • Golden State Equity Partners's ten largest holdings make up 22% of its $1.32B portfolio in Q1 2026.
  • Golden State Equity Partners opened 1,578 new positions and closed 5 in Q1 2026.
  • Golden State Equity Partners's portfolio value rose 113% quarter-over-quarter to $1.32B.

Based on Golden State Equity Partners's 13F filing for Q1 2026, filed 28 Apr 2026.